Tert Promoter Mutation As A Prognostic Marker In Patients With Advanced Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.
JOURNAL OF CLINICAL ONCOLOGY（2021）
摘要
476Background: Reliable predictive markers are lacking in patients (pts) with locally advanced or metastatic urothelial carcinoma (aUC) treated with immune checkpoint inhibitors (ICI). We sought to...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要